Trial Profile
Blocking GLP-1 action with exendin [9-39] to determine the contribution of GLP-1 to the insulinotropic effects of the DPP-4 inhibitor vildagliptin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2011
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Avexitide
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 16 Sep 2011 New trial record